NEW YORK CITY: US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the $17 billion takeover of Hospira, the two companies announced .
The deal, approved by the boards of both companies, will importantly add Hospira’s portfolio of sterile injectable treatments and biosimilar drugs to Pfizer’s broad pharma offerings.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.